Surrogacy in the UAE: Legal Framework, Limits and Payment Models
Short answer: not a blanket UAE-wide permission
As of 24 October 2026, the answer is territorial and conditional. The 2023 federal amendment removed the former express prohibition on placing an embryo in another woman’s uterus from the medically assisted reproduction law. It did not, by itself, create a complete nationwide code for every surrogacy contract, payment model, parentage question or clinic. Article 2, as amended, permits each emirate to regulate medically assisted reproduction through its own local legislation, without prejudice to Federal Articles 6–14 and 17; federal law applies to matters for which local legislation has no relevant provision.
Abu Dhabi’s Department of Health (DoH) Standard for Gestational Surrogacy, version 2, was published in December 2025 and took effect in April 2026. It applies to DoH-licensed hospitals and assisted reproductive technology (ART) clinics specifically authorised to provide the service. This is a regulated clinical pathway in Abu Dhabi, not permission for every surrogacy model throughout the UAE. Payment terms, legal parentage and recognition abroad remain points to confirm in writing before treatment.
What changed in federal law
Federal Law No. 7 of 2019 on Medically Assisted Reproduction originally included an express prohibition on a clinic fertilising the husband’s sperm and the wife’s egg and then implanting the embryo in another woman. Federal Decree-Law No. 17 of 2023 amended several provisions of the 2019 law, including its scope, eligibility rules and prohibited practices. The earlier surrogacy-specific prohibition was removed from the amended list.
The deletion matters, but it is not a stand-alone licence. Federal law still regulates ART, restricts third-party reproductive material, requires licensed centres and preserves health-authority oversight. Article 2 permits local regulation without prejudice to Federal Articles 6–14 and 17, so a local pathway cannot be assumed to override those provisions. A broad statement that “surrogacy is legal in the UAE” therefore overstates what the amendment alone establishes.
The geographical boundary: Abu Dhabi versus other emirates
The DoH Standard for Gestational Surrogacy (Full Surrogacy), version 2, is the clearest published surrogacy-specific clinical framework located. It applies only to designated, DoH-licensed hospitals and ART clinics in Abu Dhabi that are authorised to provide the service.
Do not automatically extend this pathway to Dubai, Sharjah, Ajman, Ras Al Khaimah, Fujairah or Umm Al Quwain. Dubai has its own ART-centre standards, but the materials did not establish an equivalent Dubai surrogacy-specific authorisation. The absence of a located standard is not proof that no rule exists; it means that a prospective parent should obtain written confirmation from the competent health authority and a UAE-qualified lawyer before signing, paying or transferring embryos. A clinic’s advertisement is not a substitute for regulatory authority.
Which model is covered
Abu Dhabi’s standard concerns gestational, or “full”, surrogacy. The embryo is created through IVF using the intended spouses’ own egg and sperm, and the surrogate carries the pregnancy without supplying the egg. This is materially different from traditional surrogacy, where the carrier’s own egg is used. The standard’s definition says that only the spouses provide the ovum and sperm; it is not a general route for donor eggs, donor sperm or a donated embryo.
Federal ART rules also restrict third-party use or disposal of reproductive material and prohibit commercial use of unfertilised or fertilised ova and frozen sperm. Those rules must be applied to the proposed medical and contractual steps, not merely mentioned in a contract recital. Do not assume that the 2023 amendment permits a donor-gamete arrangement, a traditional arrangement, or a transfer to a person outside the standard’s scope. If the proposed plan differs from the standard model, pause and obtain a written legal and regulatory answer before treatment begins.
Intended-parent eligibility and medical necessity
The Abu Dhabi pathway is medically indicated, not an elective route chosen only for convenience. The earlier published DoH criteria identified intended parents aged 18–47, assessment of their physical and mental ability to raise a child, and qualifying reasons such as a uterine disorder that makes implantation impossible, repeated implantation failure or recurrent pregnancy loss, or a serious condition that makes pregnancy dangerous for the intended mother or foetus. Cases outside the listed medical categories are for the DoH medical committee to assess, not automatically accepted.
The standard is framed around “spouses”. Federal Article 8(2), as amended in 2023, separately allows certain non-Muslim persons without a marriage certificate to apply to the health authority for ART, subject to a declaration concerning the child’s lineage and the prescribed approval process. Do not assume that this broader ART exception automatically creates eligibility for surrogacy. Confirm religion-related requirements, marital status, age calculation, medical criteria and any nationality-related documents directly with DoH and the authorised facility.
Surrogate eligibility and safeguards
Indexed excerpts of the current DoH Standard, Version 2, identify a surrogate aged 21–45, with a BMI of 19–30, at least one previous pregnancy but no more than four previous births, and no more than two previous caesarean sections where no isthmocele is present. It also calls for thorough medical and psychological examinations, a healthy and functioning reproductive system, no medication considered unsafe during pregnancy, and no history of illicit drug use or alcoholism. Ask the authorised facility to confirm how each criterion is assessed and documented in the individual case; do not substitute an older checklist.
The surrogate must receive meaningful medical, psychological and legal information, undergo the required screening and give specific written consent. The standard also requires consent from the surrogate’s husband where applicable. The intended parents’ consent does not replace the surrogate’s consent, and a notarised agreement does not eliminate pregnancy risks or medical decision-making duties. Ask the facility to explain, in a language the parties understand, the medical risks, the right to ask questions, the care plan, insurance and what happens if a complication or disagreement occurs. The standard also calls for access to English- and Arabic-speaking healthcare staff; if a party needs another language, ask how the facility will ensure understanding and document informed consent.
The approval and agreement pathway
Do not begin with a private matching arrangement or an informal promise. Start by confirming that the facility is currently licensed and specifically authorised to provide gestational surrogacy under DoH rules. The facility should assess eligibility and medical necessity, prepare the medical and psychological reports, obtain separate informed consents, and refer the case to the DoH Medical Committee for Gestational Surrogacy. The published standard describes review of the medical reports, legal agreement and consents; the committee may request further documents and monitors compliance.
The agreement must comply with applicable law and executive regulations and be notarised by a Notary Public before treatment proceeds. Obtain the actual proposed agreement and all consent forms before signing. They should address each party’s roles, medical care, insurance, costs and reimbursement/compensation, confidentiality, pregnancy and birth planning, and the response to foreseeable complications. Ask who will make time-sensitive medical decisions, who pays uncovered treatment, what happens after miscarriage or failed transfer, and which authority handles a dispute. Do not treat notarisation as a guarantee that every term will be enforceable in every later dispute.
Commercial versus non-commercial arrangements: the unresolved boundary
This is the point where a categorical one-line answer would be misleading. A non-commercial or altruistic arrangement generally means that the surrogate does not make a profit and that payments are confined to permitted expenses. A commercial arrangement generally includes remuneration beyond expenses, whether labelled a fee, reward, compensation or another payment. The label used in the contract is not decisive; the substance, purpose, amount and applicable law matter.
The indexed text of the DoH version 2 consent material refers to intended parents funding “the agreed compensation and reimbursement” for the surrogate’s time, health care and participation, subject to UAE law and the notarised agreement. Until the complete standard and consent annex have been confirmed, this wording should not be treated as independent permission for a commercial fee. Federal law prohibits commercial use of reproductive material, while some secondary legal guides describe commercial surrogacy as prohibited or limited to reimbursement. Those are not identical propositions: a ban on commercialising gametes or embryos is not automatically a complete rule on every payment for gestation, but the consent wording is not an unrestricted commercial licence either.
The accessible primary material does not establish a general nationwide tariff, a clear compensation cap, or a complete test separating permissible reimbursement from unlawful profit-making. Therefore, do not advertise a guaranteed commercial model or promise that any payment is lawful. Before agreeing an amount, obtain written confirmation from DoH and a UAE lawyer on which payments are permitted, what evidence and limits apply, whether lost income or non-medical costs qualify, and how the arrangement must be documented. Do not disguise a fee as “expenses” or route payments through an intermediary to evade the rules.
Insurance, costs and public-health funding
The DoH standard requires the intended parents to obtain an insurance policy covering necessary health services related to gestational surrogacy and to pay costs not covered by the policy or above its limits. It states that Thiqa, Basic, Enhanced or another government-funded programme cannot be used to cover costs or complications related to the surrogate’s health arising from surrogacy. This is an operational requirement, not a promise that a private insurer will cover every event.
No verified official price list was identified for the full programme. Ask the facility for a written, itemised estimate covering screening, IVF, genetic testing, transfer, antenatal care, delivery, postpartum care, complications, insurance, legal/notary work and any approved reimbursement or compensation. Check exclusions, limits, waiting periods and who pays if the policy refuses a claim. Do not rely on a package quote or a clinic’s verbal assurance without seeing the policy and the signed agreement.
Parentage, birth registration and the child’s status
The DoH consent forms record that the surrogate and, where applicable, her husband understand that they are not intended to be the child’s legal parents and do not intend to claim custody or parental rights. This is an important part of the regulated arrangement, but a consent form should not be mistaken for a complete answer to every question of parentage, birth registration, nationality, inheritance or recognition in another country. Secondary legal commentary continues to identify gaps, particularly around the consequences of parentage and succession.
Before treatment, obtain written instructions on the steps required after birth: which authority or court confirms parentage, which documents the birth registrar needs, how the birth certificate will be issued, and how translations, attestations or legalisations are handled. Then check nationality and travel-document requirements separately with the child’s relevant embassy or consulate and the immigration authorities. A birth certificate, a parentage decision, citizenship and permission to leave or enter a country are distinct legal questions. The Abu Dhabi clinical standard does not itself guarantee a passport, visa or recognition abroad.
What remains prohibited or cannot be assumed
The 2023 amendment did not repeal the whole ART control system. Treatment must take place in a properly licensed centre and follow applicable health-authority standards. Third-party egg/sperm combinations remain restricted under the federal law, and the Abu Dhabi standard’s own-gamete model does not provide a route for traditional surrogacy or donor-embryo arrangements. The rules on commercial use of reproductive material, consent, storage and handling remain relevant.
Nor should anyone assume that an agreement alone cures a regulatory defect. An unauthorised clinic, an unapproved procedure, missing consent, unsupported medical necessity or payment terms that conflict with applicable rules can expose the parties and providers to disputes or regulatory action. Exact consequences depend on the specific conduct and applicable law; because the controlling provision has not been individually verified, no specific penalty is stated here. Ask the regulator to identify the governing provision in writing before relying on a proposed exception.
What the federal change does not decide for you
The federal amendment, the Abu Dhabi clinical standard and a private contract perform different jobs. The federal statute establishes baseline ART controls and permits emirate-specific regulation in defined areas. The DoH standard sets clinical-governance and process requirements for facilities within its scope. The agreement allocates responsibilities among the parties, but cannot override mandatory law or guarantee how a court, registrar, insurer or foreign authority will treat the arrangement.
The 2023 amendment’s provision for certain non-Muslim persons without a marriage certificate concerns access to ART subject to stated conditions. It should not be stretched into an assumption that every unmarried person, single intended parent or same-sex couple is eligible for a surrogacy programme. The standard is drafted around spouses and their gametes. Eligibility, family status, religious status, parentage and nationality should each be assessed separately. If the intended parents or surrogate are foreign nationals, include their nationality and residence laws in the pre-treatment review rather than waiting until birth.
Practical checklist before signing or paying
Before committing funds, ask the authorised facility and your UAE lawyer to confirm in writing: (1) that the current DoH version 2 applies and the facility is specifically authorised; (2) that the intended parents and surrogate meet every current criterion; (3) that the DoH medical committee has approved the case; (4) that the proposed embryo uses only permitted gametes; (5) that all parties have received independent, understandable counselling and separate consent forms; (6) that the notarised agreement is final before treatment; and (7) that insurance covers surrogacy-related care and explains exclusions.
Also obtain a written payment schedule that distinguishes medical bills, insurance premiums, reasonable reimbursements and any compensation; ask the regulator or counsel to confirm each category rather than relying on labels. Confirm the legal steps for birth registration, parentage, nationality and travel, and preserve the medical reports, approvals, consents, notarised agreement, payment records and insurer correspondence. If the programme is outside Abu Dhabi, do not proceed until the competent emirate authority confirms a legal route. If an authority or clinic gives a verbal answer, request the rule or written approval on which it relies.
Questions that need separate answers
Does the Abu Dhabi standard automatically give the child citizenship or a travel document? No. The clinical pathway, legal parentage, citizenship by descent, passport issuance and permission to cross borders are separate issues. Confirm each with the relevant authority and embassy before embryo transfer.
Can an arrangement performed abroad automatically be used in Dubai or another emirate? No automatic recognition should be assumed. The foreign agreement and birth documents may raise separate questions of recognition, public policy, parentage and registration. Obtain advice under the law of the place where the arrangement occurs and the law of the place where the child and intended parents will live.
Sources and evidence limits
The sources below include official legislation and regulatory standards as well as secondary legal commentary. Confirm the full operative text of the 2023 amendment and DoH Standard V2 against their current official versions. Before treatment, confirm unresolved points in writing with DoH and UAE-qualified counsel; this summary is not a case-specific legal opinion.
- S1. Federal Law No. (7) of 2019 Concerning Medically Assisted Reproduction
- S2. UAE Legislation — related legislation for Federal Law No. (7) of 2019
- S3. Department of Health — Gestational Surrogacy Standard (Full Surrogacy), Version 2
- S4. Cabinet Resolution No. (64) of 2020 — Executive Regulation of Federal Law No. (7) of 2019
- S5. Dubai Health Authority — Standards for Assisted Reproductive Medicine Centers (2026)
- S6. Chambers and Partners — Private Wealth 2026, UAE: Trends and Developments
- S7. Legal 500 — UAE Family Law: Country Comparative Guide
- S8. Ministry of Health and Prevention — Federal Decree-Law No. 17 of 2023 amending Federal Law No. 7 of 2019 on medically assisted reproduction
- S9. Department of Health — Standard for Gestational Surrogacy (Full Surrogacy), Version 1 (superseded)








